Platinum-resistant ovarian cancer (PROC) remains one of the most significant challenges in gynecologic oncology; however, novel antibody-drug conjugates (ADCs) and innovative investigational therapies are opening new avenues to improve outcomes.
Novel targeted therapies offer new hope to slow progression and improve quality of life in meaningful ways for patients with primary biliary cholangitis (PBC).
Join us for a live webinar focused on the evolving role of immunotherapy in early-stage resectable non-small cell lung cancer (NSCLC).
Post-COVID conditions (PCC) refer to a diverse array of symptoms that persist for weeks, months, and even years after acute SARS-CoV-2 infection and significantly impact quality of life.
Longstanding barriers to care combined with an elevated risk of diabetic macular edema (DME) contribute to the disproportionate burden of DME in Native American communities.
Bipolar disorder (BD) is a chronic and disabling mood disorder often complicated by overlapping symptoms, frequent misdiagnosis, poor adherence, and comorbidities, leaving significant gaps in care.
Join us for a live, expert-led webinar exploring the evolving role of GPRC5D-targeted CAR T-cell therapies in multiple myeloma.
Complete all three Introduction courses (Neurotoxins, Biostimulators and HA Dermal Fillers) to earn a Clinical Aesthetics Injectables Certificate.
HER2 alterations are rare in NSCLC, but getting testing and treatment right is critical. Join this live, case-based webinar to learn when to test, explore new HER2-targeted therapies, & speed the path from detection to the right treatment.
Discover what's next in innovation and evidence, and transform your immune thrombocytopenia (ITP) care by attending this live expert exchange webinar.